Group One Trading, L.P. Myriad Genetics Inc Transaction History

Group One Trading, L.P.

  • $2.68 Billion
  • Q2 2025

A detailed history of Group One Trading, L.P. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 7,577 shares of MYGN stock, worth $57,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,577
Previous 992 663.81%
Holding current value
$57,888
Previous $8,000 400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$3.84 - $8.84 $25,286 - $58,211
6,585 Added 663.81%
7,577 $40,000
Q1 2025

May 14, 2025
BUY
$8.87 - $14.98 $8,799 - $14,860
992 New
992 $8,000
Q3 2023

Nov 09, 2023
SELL
$15.99 - $23.22 $184,540 - $267,982
-11,541 Reduced 74.0%
4,055 $65,000
Q2 2023

Aug 09, 2023
BUY
$17.56 - $23.76 $179,094 - $242,328
10,199 Added 188.98%
15,596 $361,000
Q1 2023

May 12, 2023
BUY
$15.26 - $23.75 $82,358 - $128,178
5,397 New
5,397 $125,000
Q1 2022

May 12, 2022
BUY
$22.67 - $28.01 $6,869 - $8,487
303 New
303 $8,000
Q4 2021

Feb 11, 2022
SELL
$24.13 - $32.63 $73,427 - $99,293
-3,043 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$29.97 - $36.66 $86,913 - $106,313
2,900 Added 2027.97%
3,043 $98,000
Q2 2021

Aug 10, 2021
BUY
$25.39 - $32.61 $3,630 - $4,663
143 New
143 $4,000
Q4 2020

Feb 10, 2021
SELL
$12.16 - $19.77 $348,955 - $567,339
-28,697 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$11.25 - $14.75 $7,875 - $10,325
-700 Reduced 2.38%
28,697 $374,000
Q2 2020

Aug 13, 2020
BUY
$10.69 - $16.49 $257,062 - $396,535
24,047 Added 449.48%
29,397 $333,000
Q1 2020

May 13, 2020
SELL
$9.78 - $29.53 $73,350 - $221,475
-7,500 Reduced 58.37%
5,350 $77,000
Q4 2019

Feb 10, 2020
BUY
$20.93 - $35.1 $30,097 - $50,473
1,438 Added 12.6%
12,850 $350,000
Q3 2019

Nov 12, 2019
BUY
$22.08 - $47.08 $208,015 - $443,540
9,421 Added 473.18%
11,412 $327,000
Q2 2019

Aug 09, 2019
BUY
$22.67 - $35.0 $45,135 - $69,685
1,991 New
1,991 $55,000
Q1 2019

May 13, 2019
SELL
$26.93 - $34.7 $65,305 - $84,147
-2,425 Closed
0 $0
Q4 2018

Feb 06, 2019
SELL
$27.23 - $45.56 $15,766 - $26,379
-579 Reduced 19.27%
2,425 $70,000
Q3 2018

Nov 08, 2018
SELL
$37.57 - $50.34 $148,551 - $199,044
-3,954 Reduced 56.83%
3,004 $138,000
Q2 2018

Aug 14, 2018
SELL
$27.75 - $40.17 $347,346 - $502,807
-12,517 Reduced 64.27%
6,958 $260,000
Q1 2018

May 11, 2018
SELL
$28.83 - $41.01 $285,359 - $405,916
-9,898 Reduced 33.7%
19,475 $575,000
Q4 2017

Feb 09, 2018
BUY
$28.45 - $37.14 $823,655 - $1.08 Million
28,951 Added 6860.43%
29,373 $1.01 Million
Q3 2017

Nov 15, 2017
SELL
$24.01 - $36.2 $755,786 - $1.14 Million
-31,478 Reduced 98.68%
422 $15,000
Q2 2017

Aug 14, 2017
BUY
N/A
31,900
31,900 $824,000

Others Institutions Holding MYGN

# of Institutions
234
Shares Held
95.2M
Call Options Held
460K
Put Options Held
14.2K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $616M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email